Reckitt Benckiser Group plc (LON:RKT – Get Free Report) has been assigned an average recommendation of “Hold” from the seven brokerages that are presently covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is GBX 6,279.29.
A number of research analysts recently commented on the company. JPMorgan Chase & Co. raised their price target on Reckitt Benckiser Group from GBX 5,500 to GBX 6,100 and gave the stock a “neutral” rating in a research report on Wednesday, November 26th. Citigroup assumed coverage on shares of Reckitt Benckiser Group in a report on Wednesday, January 14th. They issued a “buy” rating and a GBX 7,000 target price on the stock. Royal Bank Of Canada cut shares of Reckitt Benckiser Group to a “sector perform” rating and dropped their target price for the company from GBX 6,400 to GBX 6,200 in a research report on Wednesday, January 14th. Finally, Jefferies Financial Group increased their price target on shares of Reckitt Benckiser Group from GBX 5,500 to GBX 5,700 and gave the stock a “hold” rating in a research report on Wednesday, January 7th.
Get Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Down 0.9%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its quarterly earnings data on Thursday, March 5th. The company reported £122.58 EPS for the quarter. Reckitt Benckiser Group had a return on equity of 11.73% and a net margin of 7.27%. On average, research analysts predict that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
